Patients who undergo hematopoietic stem‐cell transplantation (HSCT) are more susceptible
to developing severe forms of COVID‐19 with an increased risk of mortality. The aim of this
study was to analyze, by performing a systematic review and meta‐analysis, all studies that
evaluated COVID‐19 in HSCT adult recipients and present clinical characteristics and
outcomes. Studies were eligible for inclusion if they:(I) described the clinical characteristics
of COVID‐19 in adult (aged 18 years old or above) HSCT recipients;(II) described outcomes …

Background Hematopoietic stem cell transplant (HSCT) recipients are at increased risk of
mortality and morbidity with coronavirus disease 2019 (COVID‐19) due to severe immune
dysfunction. Methods A literature search was performed on PubMed, Cochrane, and Clinical
trials. gov from the date of inception to 12/08/2021. We identified 19 original studies
reporting data on COVID‐19 in HSCT recipients after screening 292 articles. Data were
extracted following preferred reporting items for systematic reviews and meta‐analysis …